10:33 AM EDT, 06/12/2025 (MT Newswires) -- Tempus AI ( TEM ) has formed a collaboration with The Abrams Research Center on Neurogenomics at Northwestern University Feinberg School of Medicine to use artificial intelligence for Alzheimer's disease research.

Under the partnership, Tempus will use its AI-powered data analytics platform, Lens, to analyze and restructure the center's genomic data.

The goal is to uncover actionable insights that may support the development of targeted therapies for Alzheimer's disease, Tempus said Thursday.

Price: 70.77, Change: -0.01, Percent Change: -0.01